Personal information

Other IDs

Loop profile: 1737842

Activities

Collapse all

Employment (1)

Beckman Research Institute: Duarte, California, US

Staff Scientist (Immuno-Oncology)
Employment
Source: Self-asserted source
Gabriela Escalante

Education and qualifications (1)

Irell and Manella Graduate School of Biological Sciences of City of Hope: Duarte, California, US

PhD
Education
Source: Self-asserted source
Gabriela Escalante

Works (10)

A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow Cytometry

Viruses
2024-10 | Journal article | Author
DOI: 10.3390/v16101628
Contributors: Simeon Cua; Brenda A. Tello; MA Farelo; Esther Rodriguez; Gabriela Escalante; Lorraine Z. Mutsvunguma; jogembo; Ivana Gabriela Reidel
Source: check_circle
Multidisciplinary Digital Publishing Institute

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

Frontiers in Immunology
2024-09-13 | Journal article
DOI: 10.3389/fimmu.2024.1445209
Part of ISSN: 1664-3224
Contributors: Gabriela M. Escalante; Ivana G. Reidel; Lorraine Z. Mutsvunguma; Simeon Cua; Brenda A. Tello; Esther Rodriguez; Mafalda A. Farelo; Cloe Zimmerman; Murali Muniraju; He Li et al.
Source: Self-asserted source
Gabriela Escalante

Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection in vitro or in vivo.

Journal of virology
2024-05-20 | Journal article | Author
DOI: 10.1128/jvi.00576-24
PMID: 38767375
Contributors: Murali Muniraju; Mutsvunguma LZ; Reidel IG; Gabriela Escalante; Cua S; Musonda W; Calero-Landa J; MA Farelo; Rodriguez E; Li Z et al.
Source: Self-asserted source
Gabriela Escalante

Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.

Frontiers in immunology
2022-04-14 | Journal article
DOI: 10.3389/fimmu.2022.867918
PMID: 35493498
PMC: PMC9047024
Contributors: Escalante GM; Mutsvunguma LZ; Muniraju M; Rodriguez E; Ogembo JG
Source: Self-asserted source
Gabriela Escalante

A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits

Vaccines
2020-04 | Journal article | Author
DOI: 10.3390/vaccines8020169
Contributors: Gabriela Escalante; Joslyn Foley; Lorraine Z. Mutsvunguma; Esther Rodriguez; David Mulama; Murali Muniraju; Peng Ye; Anne K. Barasa; Javier Gordon Ogembo
Source: check_circle
Multidisciplinary Digital Publishing Institute

A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits

Vaccine
2019-07 | Journal article
DOI: 10.1016/j.vaccine.2019.04.071
Part of ISSN: 0264-410X
Source: Self-asserted source
Gabriela Escalante

Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes.

Virology
2019-07-30 | Journal article
DOI: 10.1016/j.virol.2019.07.026
PMID: 31377598
Source: Self-asserted source
Gabriela Escalante

Kaposi Sarcoma-associated Herpesvirus Glycoprotein H is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types

Journal of Virology
2019-05-29 | Journal article
DOI: 10.1128/jvi.00630-19
Part of ISSN: 0022-538X
Part of ISSN: 1098-5514
Source: Self-asserted source
Gabriela Escalante

Silicosis and Silica-Induced Autoimmunity in the Diversity Outbred Mouse.

Frontiers in immunology
2018-04-26 | Journal article
DOI: 10.3389/fimmu.2018.00874
PMID: 29755467
PMC: PMC5932595
Source: Self-asserted source
Gabriela Escalante

Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.

Journal of immunology (Baltimore, Md. : 1950)
2017-12 | Journal article
DOI: 10.4049/jimmunol.1700332
PMID: 29055005
Contributors: Pollard KM; Escalante GM; Huang H; Haraldsson KM; Hultman P; Christy JM; Pawar RD; Mayeux JM; Gonzalez-Quintial R; Baccala R et al.
Source: Self-asserted source
Gabriela Escalante via Europe PubMed Central
How many people are using ORCID?